A year ago, we first began to hear about a GSK bribery scandal in China [an irreducible conflict…]. Pharmagossip has kept us up on the developments. Now this: How a secret sex tape plunged British drugs giant Glaxo into a £90million bribery probe Daily Mail By Hugo Gye 29 June 2014 A covert sex tape […]
From: xxxxxxxxxxxxxxxxx@ec.europa.eu Dear Madam/Sir, In recent weeks, the Commission has received numerous emails, addressed to Ms Testori Coggi, in which citizens voiced their concern regarding the draft policy of the European Medicines Agency (EMA) on the publication of clinical data. We appreciate the interest that this topic triggered. The Commission values transparency as an important […]
Earlier, I mentioned "Vanessa’s Law" currently proposed in Canada [doing the right thing… and missing link…]. This is a Canadian Religious Program, "Context," where the author of that proposed legislation is interviewed:
Speaking as a Physician PsychiatricNews by Paul Summergrad, M.D. June 27, 2014 I recently covered on our inpatient psychiatry service at Tufts Medical Center. It is always valuable to see patients at the bedside and to spend time with wonderful psychiatric residents. As usual, the level of both medical psychiatric comorbidity and clinical complexity was […]
This is the sixth in a series: a madness to our method… are you listening?… another campaign?… read me him… a madness to our method – a new introduction… First, my apologies for the length and number of posts about this BMJ article. It was so heavily pushed in the press and so confusing that […]
The 1991 FDA hearing about SSRIs and suicidality was principally focused on Prozac and pitted case reports against the Clinical Trial data. My recollection is that the general thought was that this was seen as a campaign initiated by the Scientologists and it didn’t have a major impact at the time. But the second time […]
I’m about to hit the road to visit an old friend on the other end of the South for a few days and will be out of pocket, but I didn’t want to take off without linking to this article about the BMJ study at hand [Changes in antidepressant use by young people and suicidal […]
First off, thanks to Suzanna for sending along a tutorial about QUASI-EXPERIMENTAL RESEARCH DESIGNS [I must’ve cut that lecture in psychoanalytic training]. Likewise, thanks to Dr. Carroll for his looking over Dr. Lu’s article [how does he see all that stuff?]. The tips are a big help in reading the article without my eyes crossing. […]
If you go to the Department of Population Medicine website, the home of Christine Lu, MSc, PhD, first author of the article in my last post [a madness to our method…], you’ll notice two logos. One is the familiar Harvard Medical School logo [currently featuring Unintended Danger from Antidepressant Warnings], the other is something called […]
Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study by Christine Y Lu, Fang Zhang, Matthew D Lakoma, Jeanne M Madden, Donna Rusinak, Robert B Penfold, Gregory Simon, Brian K Ahmedani, Gregory Clarke, Enid M Hunkeler, Beth Waitzfelder, Ashli Owen-Smith, Marsha A Raebel, Rebecca Rossom, Karen […]